In somatic contexts, rare mutations in NSUN5 have been reported in various cancers, including hepatocellular carcinoma and glioblastoma, which can alter RNA methylation patterns and downstream signaling pathways, promoting tumor progression or affecting tumor suppressor functions (31, 45). The gene discussed is NSUN5; the disease is glioblastoma.